Defence Therapeutics Inc.

CNSX:DTC ISIN:CA24463V1013

Located in Quebec, Canada, the Defence Therapeutics Inc. (CNSX:DTC) (FRA:DTC) (OTCMKTS:DTCFF) leadership team brings extensive experience in the capital markets, finance, biochemistry, pharmacology, biotech, immunology. Together they have developed the company's IP and are leading the current product pipeline.

 
 

News

Ellis Martin Report: Dr. Amie Phinney of Defence Therapeutics Inc. (CNSX:DTC) on the Accum(TM) Platform

🕔9/23/2025 1:31:33 PM 1257

In this episode of The Ellis Martin Report on Money Talk Radio, Ellis speaks with Dr. Amie Phinney, Strategy and Business Advisor at Defence Therapeutics Inc. (CNSX:DTC) (FRA:DTC) (OTCMKTS:DTCFF).

Read Full Article

Ellis Martin Report: Defence Therapeutics Inc. (CNSX:DTC) Dr. Moutih Rafei-Developing Vaccines and Platform Technologies for the Treatment of Cancer

🕔6/12/2024 10:47:17 AM 6050

Join Ellis Martin and Money Talk Radio for a conversation with Dr. Moutih Rafei, Chief Science Officer of Defence Therapeutics (CNSX:DTC) (FRA:DTC) (OTCMKTS:DTCFF).

Read Full Article
###

1,357 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 417) (Last 30 Days: 448) (Since Published: 1357) 

Company Data

    Headquarters
  • 7171 Frederick Banting St.
    Montreal, QC, H4S 1Z9
    Canada
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.defencetherapeutics.com/